vs

Side-by-side financial comparison of INSMED Inc (INSM) and WESBANCO INC (WSBC). Click either name above to swap in a different company.

INSMED Inc is the larger business by last-quarter revenue ($263.8M vs $257.2M, roughly 1.0× WESBANCO INC). WESBANCO INC runs the higher net margin — 34.5% vs -124.5%, a 159.0% gap on every dollar of revenue. Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs 31.9%).

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

WesBanco, Inc., is a bank holding company headquartered in Wheeling, West Virginia, United States. It has over 200 branches in West Virginia, Ohio, Western Pennsylvania, Kentucky, Maryland, and Southern Indiana.

INSM vs WSBC — Head-to-Head

Bigger by revenue
INSM
INSM
1.0× larger
INSM
$263.8M
$257.2M
WSBC
Higher net margin
WSBC
WSBC
159.0% more per $
WSBC
34.5%
-124.5%
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
31.9%
WSBC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
INSM
INSM
WSBC
WSBC
Revenue
$263.8M
$257.2M
Net Profit
$-328.5M
$88.6M
Gross Margin
83.2%
Operating Margin
-121.2%
Net Margin
-124.5%
34.5%
Revenue YoY
152.6%
Net Profit YoY
-39.5%
54.4%
EPS (diluted)
$-1.55
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSM
INSM
WSBC
WSBC
Q1 26
$257.2M
Q4 25
$263.8M
$265.6M
Q3 25
$142.3M
$261.6M
Q2 25
$107.4M
$260.7M
Q1 25
$92.8M
$193.2M
Q4 24
$104.4M
$162.9M
Q3 24
$93.4M
$150.8M
Q2 24
$90.3M
$147.9M
Net Profit
INSM
INSM
WSBC
WSBC
Q1 26
$88.6M
Q4 25
$-328.5M
$91.1M
Q3 25
$-370.0M
$83.6M
Q2 25
$-321.7M
$57.4M
Q1 25
$-256.6M
$-9.0M
Q4 24
$-235.5M
$49.6M
Q3 24
$-220.5M
$37.3M
Q2 24
$-300.6M
$28.9M
Gross Margin
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
83.2%
Q3 25
79.4%
Q2 25
73.9%
Q1 25
77.1%
Q4 24
75.0%
Q3 24
77.3%
Q2 24
76.8%
Operating Margin
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
-121.2%
43.2%
Q3 25
-257.1%
39.5%
Q2 25
-291.3%
27.2%
Q1 25
-267.3%
-5.0%
Q4 24
-220.6%
38.0%
Q3 24
-228.4%
29.7%
Q2 24
-319.8%
23.7%
Net Margin
INSM
INSM
WSBC
WSBC
Q1 26
34.5%
Q4 25
-124.5%
34.3%
Q3 25
-260.0%
31.9%
Q2 25
-299.5%
22.0%
Q1 25
-276.4%
-4.7%
Q4 24
-225.5%
30.5%
Q3 24
-236.0%
24.7%
Q2 24
-332.8%
19.5%
EPS (diluted)
INSM
INSM
WSBC
WSBC
Q1 26
$0.88
Q4 25
$-1.55
$0.97
Q3 25
$-1.75
$0.84
Q2 25
$-1.70
$0.57
Q1 25
$-1.42
$-0.15
Q4 24
$-1.30
$0.72
Q3 24
$-1.27
$0.54
Q2 24
$-1.94
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSM
INSM
WSBC
WSBC
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$546.8M
Stockholders' EquityBook value
$739.0M
$4.1B
Total Assets
$2.3B
$27.5B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
$1.4B
$956.1M
Q3 25
$1.7B
$1.0B
Q2 25
$1.9B
$1.2B
Q1 25
$1.2B
$1.1B
Q4 24
$1.4B
$568.1M
Q3 24
$1.5B
$620.9M
Q2 24
$1.2B
$486.8M
Total Debt
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
$546.8M
Q3 25
$546.8M
Q2 25
$546.8M
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$971.8M
Q2 24
$1.2B
Stockholders' Equity
INSM
INSM
WSBC
WSBC
Q1 26
$4.1B
Q4 25
$739.0M
$4.0B
Q3 25
$945.6M
$4.1B
Q2 25
$1.2B
$3.8B
Q1 25
$99.2M
$3.8B
Q4 24
$285.4M
$2.8B
Q3 24
$483.4M
$2.8B
Q2 24
$38.8M
$2.5B
Total Assets
INSM
INSM
WSBC
WSBC
Q1 26
$27.5B
Q4 25
$2.3B
$27.7B
Q3 25
$2.4B
$27.5B
Q2 25
$2.5B
$27.6B
Q1 25
$1.8B
$27.4B
Q4 24
$2.0B
$18.7B
Q3 24
$2.1B
$18.5B
Q2 24
$1.8B
$18.1B
Debt / Equity
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
0.74×
Q3 25
0.58×
Q2 25
0.44×
Q1 25
11.31×
Q4 24
3.93×
Q3 24
2.01×
Q2 24
30.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSM
INSM
WSBC
WSBC
Operating Cash FlowLast quarter
$-247.6M
Free Cash FlowOCF − Capex
$-264.2M
FCF MarginFCF / Revenue
-100.1%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
$-247.6M
$290.4M
Q3 25
$-219.8M
$116.9M
Q2 25
$-205.6M
$105.0M
Q1 25
$-262.1M
$-26.4M
Q4 24
$-196.0M
$211.0M
Q3 24
$-180.9M
$60.7M
Q2 24
$-123.0M
$18.2M
Free Cash Flow
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
$-264.2M
$280.0M
Q3 25
$-222.2M
$114.9M
Q2 25
$-209.1M
$98.3M
Q1 25
$-272.2M
$-30.7M
Q4 24
$-202.8M
$200.7M
Q3 24
$-184.6M
$56.9M
Q2 24
$-129.7M
$17.3M
FCF Margin
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
-100.1%
105.4%
Q3 25
-156.1%
43.9%
Q2 25
-194.6%
37.7%
Q1 25
-293.2%
-15.9%
Q4 24
-194.1%
123.2%
Q3 24
-197.6%
37.7%
Q2 24
-143.6%
11.7%
Capex Intensity
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
6.3%
3.9%
Q3 25
1.7%
0.8%
Q2 25
3.2%
2.6%
Q1 25
10.8%
2.2%
Q4 24
6.5%
6.3%
Q3 24
3.9%
2.5%
Q2 24
7.5%
0.6%
Cash Conversion
INSM
INSM
WSBC
WSBC
Q1 26
Q4 25
3.19×
Q3 25
1.40×
Q2 25
1.83×
Q1 25
Q4 24
4.25×
Q3 24
1.63×
Q2 24
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INSM
INSM

Segment breakdown not available.

WSBC
WSBC

Net Interest Income$215.4M84%
Noninterest Income$41.8M16%

Related Comparisons